Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to 5.71%.

  • cbdMD's EBITDA Margin fell 40200.0% to 5.71% in Q4 2025 from the same period last year, while for Dec 2025 it was 12.37%, marking a year-over-year decrease of 4900.0%. This contributed to the annual value of 11.27% for FY2025, which is 53700.0% up from last year.
  • According to the latest figures from Q4 2025, cbdMD's EBITDA Margin is 5.71%, which was down 40200.0% from 14.53% recorded in Q3 2025.
  • cbdMD's EBITDA Margin's 5-year high stood at 1.69% during Q4 2024, with a 5-year trough of 373.55% in Q2 2022.
  • Over the past 5 years, cbdMD's median EBITDA Margin value was 30.21% (recorded in 2023), while the average stood at 75.72%.
  • As far as peak fluctuations go, cbdMD's EBITDA Margin tumbled by -3147500bps in 2022, and later skyrocketed by 3453300bps in 2023.
  • Over the past 5 years, cbdMD's EBITDA Margin (Quarter) stood at 255.1% in 2021, then soared by 75bps to 64.84% in 2022, then skyrocketed by 69bps to 19.83% in 2023, then surged by 91bps to 1.69% in 2024, then tumbled by -238bps to 5.71% in 2025.
  • Its last three reported values are 5.71% in Q4 2025, 14.53% for Q3 2025, and 19.64% during Q2 2025.